<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HET</journal-id>
<journal-id journal-id-type="hwp">sphet</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Exp Toxicol</journal-id>
<journal-title>Human &amp; Experimental Toxicology</journal-title>
<issn pub-type="ppub">0960-3271</issn>
<issn pub-type="epub">1477-0903</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0960327111424305</article-id>
<article-id pub-id-type="publisher-id">10.1177_0960327111424305</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effect of transient TCDD exposure on immortalized human trophoblast-derived cell lines</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111424305">1</xref>
<xref ref-type="corresp" rid="corresp1-0960327111424305"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff2-0960327111424305">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111424305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takao</surname>
<given-names>T</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111424305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morokuma</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111424305">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kato</surname>
<given-names>K</given-names>
</name>
<xref ref-type="aff" rid="aff3-0960327111424305">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<xref ref-type="aff" rid="aff4-0960327111424305">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takeda</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff3-0960327111424305">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsumura</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff5-0960327111424305">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wake</surname>
<given-names>N</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111424305">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0960327111424305"><label>1</label>Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan</aff>
<aff id="aff2-0960327111424305"><label>2</label>Department of Obstetrics, Fukuoka Children’s Hospital, Fukuoka, Japan</aff>
<aff id="aff3-0960327111424305"><label>3</label>Department of Obstetrics and Gynecology, Juntendo University, Tokyo, Japan</aff>
<aff id="aff4-0960327111424305"><label>4</label>Department of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Saitama, Japan</aff>
<aff id="aff5-0960327111424305"><label>5</label>Department of Nutrition Management, Hyogo University, Hyogo, Japan</aff>
<author-notes>
<corresp id="corresp1-0960327111424305">Kotaro Fukushima, Department of Obstetrics and Gynecology, Kyushu University Hospital, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan Email: <email>kfuku@gynob.med.kyushu-u.ac.jp</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>31</volume>
<issue>6</issue>
<fpage>550</fpage>
<lpage>556</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Low level, antenatal exposure to dioxins is associated with low birth weight, which in turn is associated with long-term sequelae. We exposed the human extravillous cytotrophoblast (EVT) lines HTR-8/SV40 and TCL1 to 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) and assessed cell growth, invasion, and differentiation. TCDD had no effect on cell proliferation, invasion, or tube formation in Matrigel. The EVT-derived cells expressed a functional aryl hydrocarbon receptor protein; however, TCDD exposure did not alter expression levels of proteins involved in EVT differentiation in early pregnancy, including hypoxia-inducible factor 1A (HIF1A), vascular endothelial growth factor (VEGF), Integrin A1, A6, and AVB3. These results suggest that the reduction in fetal weight induced by dioxin is not the result of vascular remodeling via EVT dysfunction.</p>
</abstract>
<kwd-group>
<kwd>pregnancy</kwd>
<kwd>placenta</kwd>
<kwd>trophoblast</kwd>
<kwd>2, 3, 7, 8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0960327111424305">
<title>Introduction</title>
<p>Several studies have associated antenatal low-level dioxin exposure with low birth weight.<sup><xref ref-type="bibr" rid="bibr1-0960327111424305">1</xref><xref ref-type="bibr" rid="bibr2-0960327111424305"/><xref ref-type="bibr" rid="bibr3-0960327111424305"/>–<xref ref-type="bibr" rid="bibr4-0960327111424305">4</xref></sup> Low birth weight in turn increases the risk of developmental delay and learning disabilities,<sup><xref ref-type="bibr" rid="bibr5-0960327111424305">5</xref></sup> high blood pressure<sup><xref ref-type="bibr" rid="bibr6-0960327111424305">6</xref></sup> and cardiovascular disease.<sup><xref ref-type="bibr" rid="bibr7-0960327111424305">7</xref>,<xref ref-type="bibr" rid="bibr8-0960327111424305">8</xref></sup> Thus, it is important to determine the mechanism by which dioxins affect birth weight as an initial step in managing the effects of dioxin exposure in pregnancy.</p>
<p>The biochemical and toxic effects of the most potent dioxin, 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD), are mediated by its binding to the aryl hydrocarbon receptor (AhR). The AhR mediates the induction of cytochrome P450 (CYP) enzymes. Induction of these CYP enzymes in turn causes leakage of oxidants, thereby promoting oxidative DNA damage.<sup><xref ref-type="bibr" rid="bibr9-0960327111424305">9</xref></sup> In utero exposure to TCDD markedly suppresses the development of sinusoids and trophoblast cells and induces apoptosis of trophoblast cells with a concomitant increase in the incidence of fetal death in the setting of hypoxia. Cross talk between the hypoxia-inducible factor (HIF)-mediated pathway and the AhR-mediated pathway plays an important role in this physiological process.<sup><xref ref-type="bibr" rid="bibr10-0960327111424305">10</xref></sup> One HIF member, HIF1A, also plays a key role in the regulation of extravillous cytotrophoblast (EVT) differentiation.<sup><xref ref-type="bibr" rid="bibr11-0960327111424305">11</xref><xref ref-type="bibr" rid="bibr12-0960327111424305"/><xref ref-type="bibr" rid="bibr13-0960327111424305"/>–<xref ref-type="bibr" rid="bibr14-0960327111424305">14</xref></sup> It is therefore plausible that TCDD, by increasing Reactive Oxygen Species (ROS), may directly affect EVT function during placental development and may cause fetal growth restriction via placental dysfunction. There is little evidence, however, that TCDD affects the biological behavior of trophoblast cells.<sup><xref ref-type="bibr" rid="bibr9-0960327111424305">9</xref>,<xref ref-type="bibr" rid="bibr10-0960327111424305">10</xref></sup> In this study, we transiently exposed two human EVT cell lines to TCDD to investigate the effects of TCDD on cell growth, invasion, and differentiation.</p>
</sec>
<sec id="section2-0960327111424305">
<title>Materials and methods</title>
<sec id="section3-0960327111424305">
<title>Reagents</title>
<p>TCDD was purchased from Sigma Chemical Co. (St Louis, MO, USA). An HIF1A antibody was purchased from BD Transduction Laboratories (Bedford, MA, USA). The vascular endothelial growth factor (VEGF) antibody was purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The AhR antibody was purchased from Thermo Scientific (Rodford, IL, USA). The CYP1A1 antibody was purchased from Enzo Life Science Inc. (Plymouth, PA, USA). The aryl hydrocarbon receptor nuclear translocator (ARNT) antibody was purchased from Affinity BioReagents, (Golden, CO, USA). The Integrin A1, A6, AVB3 antibodies were purchased from Chemicon International Inc. (Temecula, CA, USA). Fluorescein isothiocyanate (FITC)-conjugated anti-mouse immunoglobulin G ([IgG] Molecular Probes Inc, Eugene, OR, USA) was used as a secondary antibody.</p>
</sec>
<sec id="section4-0960327111424305">
<title>Cell lines and cell culture</title>
<p>TCL1 cells were established from mixed primary cultures of cells isolated from chorionic membranes obtained at the time of elective, preterm caesarean sections.<sup><xref ref-type="bibr" rid="bibr11-0960327111424305">11</xref><xref ref-type="bibr" rid="bibr12-0960327111424305"/><xref ref-type="bibr" rid="bibr13-0960327111424305"/><xref ref-type="bibr" rid="bibr14-0960327111424305"/>–<xref ref-type="bibr" rid="bibr15-0960327111424305">15</xref></sup> The HTR-8Svneo first-trimester cytotrophoblast cell line, established as described previously,<sup><xref ref-type="bibr" rid="bibr16-0960327111424305">16</xref></sup> was cultured in RPMI1640 (Nipro, Tokyo, Japan) supplemented with 10% fetal calf serum (FCS, Gibco Invitrogen) or conditioned serum in a humidified atmosphere containing 95% air and 5% CO<sub>2</sub> at 37°C.</p>
</sec>
<sec id="section5-0960327111424305">
<title>WST assay</title>
<p>Cellular proliferation was measured both by direct counting and with the WST assay. The WST assay was performed using a commercially available kit (Premix WST-1 Cell Proliferation Assay System, Takara, Shiga, Japan) according to the manufacturer’s protocol. In brief, 5 × 10<sup>3</sup> TCL1 cells were seeded in a 96-well microplate and exposed to TCDD/dimethyl sulfoxide (DMSO) for 24 hours. Cells were then incubated in the presence of the WST reagent for 2 hours, and the absorbance at 450 nm was measured and used to estimate the cell count.</p>
</sec>
<sec id="section6-0960327111424305">
<title>Detection of apoptosis</title>
<p>Apoptosis was confirmed by a terminal deoxynucleotidyl transferase (TdT)-mediated digoxigenin uridine triphosphate (dUTP) nick-end labeling (TUNEL) assay using a commercially available kit (TUNEL Label Mix; Roche Diagnostics, Tokyo Japan), according to the manufacturer’s protocol. Cells were viewed (magnification ×40 to ×400) and photographed using a microscope, BZ-8100 (KEYENCE, Tokyo, Japan). The number of apoptotic cells was measured by counting the number of TUNEL-positive cells. At least three fields per well were examined; each experimental condition was tested in triplicate.</p>
</sec>
<sec id="section7-0960327111424305">
<title>In vitro migration assay</title>
<p>A quantitative measure of the in vitro invasive ability of TCL1 cells was obtained in a modified Boyden Chamber assay (BD Biosciences, Franklin Lakes, NJ, USA) according to the manufacturer’s protocol. Briefly, after pretreatment with various agents, a 0.5 mL suspension of TCL1 in serum-free media was added to the upper compartment of the Boyden chamber at a density of 2 × 10<sup>5</sup> cells/well and incubated for 24 hours at 37°C, with 10% fetal bovine serum (FBS)-supplemented media in the lower compartment. Nonmigrating cells were removed with a cotton swab and the remaining cells were fixed and stained (Diff-Quick Stain Set, Dade Behring, Inc., Newark, DE, USA). Filters were removed from the chamber and mounted for visualization under a Nikon Eclipse TS100 (Nikon, Tokyo, Japan). The number of cells migrating to the lower side of the filter was determined by counting all invading cells in each membrane.</p>
</sec>
<sec id="section8-0960327111424305">
<title>Cell scratch migration assay</title>
<p>Cells were plated in 24-well plates and allowed to form a confluent monolayer. The cell surface was then scratched with a 200 μL pipette tip. Cells were photographed after 6 and 12 hours of incubation, BZ-8100 (KEYENCE, Tokyo, Japan). Cell motility was quantified with National Institutes of Health (NIH) image by measuring the area between the migrating cell boundaries in a marked high-power field. Each experimental condition was tested in triplicate.</p>
</sec>
<sec id="section9-0960327111424305">
<title>Tube-like formation assay</title>
<p>Growth factor-reduced Matrigel (BD Bioscience, Franklin Lakes, NJ, USA) was added (300 μL) to each well of a 24-well plate and allowed to polymerize for 1 hour at 37°C. After pretreatment with various agents for 2 hours, 2 × 10<sup>5</sup> TCL1 cells were seeded. Cells were incubated at 37°C at room air, viewed (magnification ×40–×400), and photographed using an Olympus IX71 microscope (Olympus, Tokyo, Japan). Tube-like formation was quantitated by counting the number of tube-like structures formed by the connected capillary bridge.<sup><xref ref-type="bibr" rid="bibr15-0960327111424305">15</xref></sup> At least three fields per well were examined; each experimental condition was tested in triplicate.</p>
</sec>
<sec id="section10-0960327111424305">
<title>Western blotting</title>
<p>Cells were lysed with lysis buffer containing 62.5 mM Tris-HCl (pH 6.8), 100 mM dithiothreitol, 2%(w/v) sodium dodecyl sulfate (SDS), and 10% glycerol. Cellular proteins were electrophoresed in an SDS gel together with a prestained molecular weight marker (BioRad Laboratories, Hercules, CA, USA), transferred onto Immobilon-P (Millipore, Bedford, MA, USA), and analyzed by an immunoblotting system (GE Healthcare Japan, Tokyo, Japan).</p>
</sec>
</sec>
<sec id="section11-0960327111424305">
<title>Results</title>
<sec id="section12-0960327111424305">
<title>HTR-8/SV40 and TCL1 cells express the functional AhR</title>
<p>To address whether HTR-8/SV40 and TCL1 cells express the functional TCDD receptor, we performed an immunoblot analysis for the AhR and CYP1A1 (<xref ref-type="fig" rid="fig1-0960327111424305">Figure 1A</xref>). Both cell types showed AhR protein expression. After incubation with 1 nM of TCDD, CYP1A1 was induced consistent with a functional AhR.</p>
<fig id="fig1-0960327111424305" position="float">
<label>Figure 1.</label>
<caption>
<p>Cellular proliferative activity. (A) Asynchronously growing HTR and TCL1 cells were incubated with 1 nM/2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) for 24 hours. Cellular proteins were then extracted, electrophoresed, and transferred onto Immobilon-P membranes before analysis by immunoblotting using the indicated antibodies. (B) Asynchronously growing TCL1 cells were seeded at 2 × 10<sup>5</sup>/100 mm dish and grown at 37°C. After 1 day of incubation, the medium was replaced with complete medium containing 10% fetal bovine serum (FBS) and the indicated concentration of TCDD. At the indicated time, cells were harvested and both the adherent and nonadherent cells were counted with a Coulter counter. Triangle: 0, Box: 0.1, Circle: 1, and X: 10 nM of TCDD. (C) Asynchronously growing cells were seeded in a 96-well microplate and treated with TCDD/DMSO for 24 hours. A WST assay was then performed using a commercially available kit. Data are represented as the mean ± SD of three independent trials. </p>
</caption>
<graphic alternate-form-of="fig1-0960327111424305" xlink:href="10.1177_0960327111424305-fig1.tif"/>
</fig>
</sec>
<sec id="section13-0960327111424305">
<title>TCDD did not affect cellular proliferation and viability in HTR-8/SV40 or TCL1 cells</title>
<p>To examine the effect of TCDD on proliferative activity, we measured cellular growth. After either a 24- or 48-hour incubation with 0.1, 1, or 10 nM of TCDD, there was no significant alteration in cellular growth of TCL or HTR cells (<xref ref-type="fig" rid="fig1-0960327111424305">Figure 1B</xref>). The relative number of HTR-8/SV40 cells following incubation with 0, 0.1, 1, or 10 nM of TCDD for 24 hours were 2.17 ± 0.19, 2.25 ± 0.38, 2.14 ± 0.11, or 2.20 ± 0.11, respectively. At 48 hours of incubation, there were 3.55 ± 0.41, 3.85 ± 0.23, 3.80 ± 0.15, or 4.14 ± 0.26 cells, respectively (<xref ref-type="fig" rid="fig1-0960327111424305">Figure 1A</xref>, Left column). The relative numbers of cells following incubation with 0, 0.1, 1, or 10 nM of TCDD for 24 hours were 1.76 ± 0.15, 1.68 ± 0.21, 1.73 ± 0.09, or 1.79 ± 0.11, respectively. At 48 hours of incubation, there were 1.30 ± 0.15, 1.21 ± 0.14, or 0.93 ± 0.13 cells, respectively. At 24 hours, there were 2.88 ± 0.33, 3.23 ± 0.30, 3.09 ± 0.12, or 3.36 ± 0.26, respectively (<xref ref-type="fig" rid="fig1-0960327111424305">Figure 1B</xref>, Right column).</p>
<p>A WST assay was then performed following a 24-hour incubation with 0.1, 1, or 10 nM of TCDD in these cells. The relative absorbance value at 450 nM after 24 hours of incubation with 0.1, 1, or 10 nM of TCDD compared to the control was 1.08 ± 0.01, 1.08 ± 0.02, or 1.08 ± 0.04, respectively, in HTR cells and 1.47 ± 0.13 and 0.98 ± 0.08, 0.95 ± 0.04, or 0.95 ± 0.11, respectively, in TCL1 cells (<xref ref-type="fig" rid="fig1-0960327111424305">Figure 1C</xref>). We also performed a TUNEL assay in TCL1 and HTR-8/SV40 cells after a 24-hour incubation with 0.1, 1, or 10 nM of TCDD; however, there was no significant difference in the number of apoptotic cells (data not shown).</p>
</sec>
<sec id="section14-0960327111424305">
<title>TCDD did not affect cellular invasive activities in HTR-8/SV40 or TCL1 cells</title>
<p>To examine the effect of TCDD on the invasion ability of TCL1 and HTR-Neo, we performed a pore membrane motility assay using the modified Boyden-chamber method. The number of invading cells after a 24-hour incubation with 0.1, 1, or 10 nM TCDD was 40.7 ± 4.0, 42.0 ± 6.1, 39.7 ± 8.5, or 42.0 ± 4.6, respectively, in HTR cells (<xref ref-type="fig" rid="fig2-0960327111424305">Figure 2A</xref>, left column) and 48.7 ± 5.5, 46.7 ± 6.1, 48.7 ± 4.5, or 47.3 ± 6.5, respectively, in TCL1 cells (<xref ref-type="fig" rid="fig2-0960327111424305">Figure 2A</xref>, right column).</p>
<fig id="fig2-0960327111424305" position="float">
<label>Figure 2.</label>
<caption>
<p>Cellular invasive activity. (A) The number of mi-grating cells was counted in each Boyden chamber membrane. Data are the mean ± SD of three independent trials. (B) A cell monolayer was scratched using a 200-μL pipette tip. Cells were photographed after 6 and 12 hours. Cell motility was quantified by measuring the area between the migrating cell boundaries in marked high-power fields with National Institutes of Health image. Data are the mean ± SD of three independent trials. Triangle: 0, Box: 0.1, Circle: 1, and X: 10 nM of 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD).</p>
</caption>
<graphic alternate-form-of="fig2-0960327111424305" xlink:href="10.1177_0960327111424305-fig2.tif"/>
</fig>
<p>We then performed a cell scratch test using HTR-8/SV40 and TCL1 cells. The relative split area compared to time 0 after a 12-hour incubation with 0, 0.1, 1, or 10 nM of TCDD was 0.11 ± 0.08, 0.13 ± 0.10, 0.18 ± 0.07, and 0.16 ± 0.02, respectively, in HTR-neo cells (<xref ref-type="fig" rid="fig2-0960327111424305">Figure 2B</xref>, Left column) and 0.08 ± 0.06, 0.17 ± 0.09, 0.10 ± 0.02, and 0.12 ± 0.07, respectively, in TCL1 cells (<xref ref-type="fig" rid="fig2-0960327111424305">Figure 2B</xref>, Right column). As shown in <xref ref-type="fig" rid="fig3-0960327111424305">Figure 3A</xref>, there was no dose-dependent effect of TCDD exposure on cell migration.</p>
<fig id="fig3-0960327111424305" position="float">
<label>Figure 3.</label>
<caption>
<p>Tube formation activity in TCL1 cells. (A) Chronological morphology during tube formation by TCL1 cells after 0 (left) and 12 hours (right) seeded on polymerized Matrigel. Bars: 50 μm. Capillary networks (arrow). (B) The number of capillary networks (arrow in A) per 1-mm<sup>2</sup> surface area was counted at magnification ×400. Data are represented as the mean + SD in three independent trials.</p>
</caption>
<graphic alternate-form-of="fig3-0960327111424305" xlink:href="10.1177_0960327111424305-fig3.tif"/>
</fig>
</sec>
<sec id="section15-0960327111424305">
<title>TCDD did not affect tube-formation activities in TCL1</title>
<p>Following 12 hours of incubation on Matrigel, TCL1 cells exhibited a morphological change that mimicked endothelial cells termed tube-like formation (<xref ref-type="fig" rid="fig3-0960327111424305">Figure 3A</xref>). After incubation with 0, 0.1, 1, or 10 nM of TCDD for 8 hours, the number of capillary networks (arrow) was 14.7 ± 2.5, 14.0 ± 4.6, 15.7 ± 3.5, or 14.3 ± 3.1, respectively (<xref ref-type="fig" rid="fig3-0960327111424305">Figure 3B</xref>).</p>
</sec>
<sec id="section16-0960327111424305">
<title>TCDD did not affect the expression of proteins related to EVT differentiation</title>
<p>We then performed a Western blot analysis to examine the expression of HIF1A, VEGF, ITGA1, A6, AVB3, which are associated with EVT differentiation. Following incubation with 0, 0.1, 1, or 10 nM of TCDD for 24 or 48 hours, there was no significant change in the expression levels of these proteins (<xref ref-type="fig" rid="fig4-0960327111424305">Figure 4</xref>).</p>
<fig id="fig4-0960327111424305" position="float">
<label>Figure 4.</label>
<caption>
<p>Immunoblotting analysis. Asynchronously growing cells were incubated with 1 nM/2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) for 24 or 48 hours. Cellular proteins were then extracted, electrophoresed, and transferred onto Immobilon-P before analysis by immunoblotting using the indicated antibodies.</p>
</caption>
<graphic alternate-form-of="fig4-0960327111424305" xlink:href="10.1177_0960327111424305-fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="section17-0960327111424305">
<title>Discussion</title>
<p>It is plausible that TCDD affects fetal growth through a variety of mechanisms including directly, following crossing the placenta, and indirectly through disruption of placental development and or endocrine function. Short- and long-term exposure to TCDD may produce different effects. Our study did not demonstrate an effect of short-term TCDD exposure on EVT growth, differentiation, or function. </p>
<p>EVT differentiation has two modes: one is endovascular differentiation, in which EVT replaces and remodels spiral arteries resulting in increased blood flow toward the intervillous space. The other is interstitial invasion, which promotes placental anchorage and is accompanied by endovascular invasion.<sup><xref ref-type="bibr" rid="bibr17-0960327111424305">17</xref>,<xref ref-type="bibr" rid="bibr18-0960327111424305">18</xref></sup> Each type is characterized by its own expression pattern of differentiation markers. These gene expression alterations are essential for organization of the fetomaternal interface during early development. For example, integrin subunit conversion during interstitial and endovascular differentiation is well characterized,<sup><xref ref-type="bibr" rid="bibr19-0960327111424305">19</xref>,<xref ref-type="bibr" rid="bibr20-0960327111424305">20</xref></sup> and this conversion is defective in patients with placental insufficiency. </p>
<p>In the rat, placental vascular remodeling occurs late in gestation and is characterized by changes in the trophoblast shape and the elimination of trophoblasts by apoptosis.<sup><xref ref-type="bibr" rid="bibr10-0960327111424305">10</xref></sup> As a result, the net volumes of both the maternal and fetal blood in the placenta increase to meet the requirements for oxygen and nutrients in late gestation. In utero exposure to TCDD markedly suppresses these placental changes and rendered the fetus more susceptible to death from hypoxia. No changes were observed in the cross talk between the HIF-mediated pathway and the AhR-mediated pathway in rats.<sup><xref ref-type="bibr" rid="bibr10-0960327111424305">10</xref></sup>
</p>
<p>Controversy exists as to whether TCDD directly affects trophoblastic function as there are few studies investigating this.<sup><xref ref-type="bibr" rid="bibr21-0960327111424305">21</xref><xref ref-type="bibr" rid="bibr22-0960327111424305"/><xref ref-type="bibr" rid="bibr23-0960327111424305"/>–<xref ref-type="bibr" rid="bibr24-0960327111424305">24</xref></sup> TCDD has been shown to significantly increase apoptosis in JAR cells in a dose-dependent manner.<sup><xref ref-type="bibr" rid="bibr21-0960327111424305">21</xref></sup> Neither TCDD nor a polychlorinated dibenzo-<italic>p</italic>-dioxin/polychlorinated dibenzo-p-furan (PCDD/PCDF) mixture, however, induces DNA damage or apoptosis in the human placental choriocarcinoma JEG-3 cell line.<sup><xref ref-type="bibr" rid="bibr22-0960327111424305">22</xref></sup> Additionally, while TCDD has been shown to have differential effects on early, late gestational, and term trophoblasts, dioxins do not affect the viability of primary cultured placental trophoblast cells in vitro.<sup><xref ref-type="bibr" rid="bibr23-0960327111424305">23</xref></sup> There are, however, differences in the reported doses of TCDD required to induce cell apoptosis. Finally, TCDD exposure increases early fetal loss, possibly due to an endocrine imbalance that leads to placental insufficiency and compromised embryonic circulation.<sup><xref ref-type="bibr" rid="bibr24-0960327111424305">24</xref></sup>
</p>
<p>In the present study, 0.1-10 nM of TCDD, equivalent to a high human exposure level,<sup><xref ref-type="bibr" rid="bibr21-0960327111424305">21</xref>,<xref ref-type="bibr" rid="bibr25-0960327111424305">25</xref></sup> did not affect the functional behavior, differentiation or protein expression of EVT-derived cell lines with respect to the HIF1A-VEGF system. This is consistent with what has been observed in the Japanese Yusho study, which followed pregnant women exposed to dioxins. In these women, despite an increased incidence of fetal growth restriction and miscarriage, there was no increase in the incidence of severe preeclampsia, the expected consequence of trophoblast dysfunction.<sup><xref ref-type="bibr" rid="bibr25-0960327111424305">25</xref><xref ref-type="bibr" rid="bibr26-0960327111424305"/>–<xref ref-type="bibr" rid="bibr27-0960327111424305">27</xref></sup>
</p>
<p>TCDD and HxCDD inhibit growth by decreasing insulin-like growth factor 1 (IGF-1) signaling in rats.<sup><xref ref-type="bibr" rid="bibr28-0960327111424305">28</xref></sup> Both TCDD and PCDD/PCDF also inhibit hCG secretion in human placental JEG-3 cell line.<sup><xref ref-type="bibr" rid="bibr21-0960327111424305">21</xref></sup> These observations taken together with our results suggest that the effect on fetal growth may be the result of an endocrine mechanism rather than impaired trophoblast function.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>The authors thank A. Noguchi for her technical assistance.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1-0960327111424305">
<p>This work was supported in part by a grant-in-aid from the Japan Ministry of Education (23591596) and the Ministry of the Environment, Japan (C-0903).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0960327111424305">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hertz-Picciotto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>James</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Willman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Teplin</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth</article-title>. <source>Epidemiology</source> <year>2005</year>; <volume>16</volume>: <fpage>648</fpage>–<lpage>656</lpage>.</citation>
</ref>
<ref id="bibr2-0960327111424305">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Washino</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kajiwara</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Prenatal exposure to PCDDs/PCDFs and dioxin-like PCBs in relation to birth weight</article-title>. <source>Environ Res</source> <year>2009</year>; <volume>109</volume>: <fpage>906</fpage>–<lpage>913</lpage>.</citation>
</ref>
<ref id="bibr3-0960327111424305">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sagiv</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Tolbert</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Altshul</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Korrick</surname>
<given-names>SA</given-names>
</name>
</person-group>. <article-title>Organochlorine exposures during pregnancy and infant size at birth</article-title>. <source>Epidemiology</source> <year>2007</year>; <volume>18</volume>: <fpage>120</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr4-0960327111424305">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sonneborn</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Petrik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kocan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palkovicova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Trnovec</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Prenatal polychlorinated biphenyl exposures in eastern Slovakia modify effects of social factors on birthweight</article-title>. <source>Paediatr Perinat Epidemiol</source> <year>2008</year>; <volume>22</volume>: <fpage>202</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr5-0960327111424305">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weindrich</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jennen-Steinmetz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Laucht</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>MH</given-names>
</name>
</person-group>. <article-title>Late sequelae of low birthweight: mediators of poor school performance at 11 years</article-title>. <source>Dev Med Child Neurol</source> <year>2003</year>; <volume>45</volume>: <fpage>463</fpage>–<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr6-0960327111424305">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>ell</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Newsome</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Syddall</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Shinebourne</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Fayers</surname>
<given-names>PM</given-names>
</name>
<etal/>
</person-group>. <article-title>Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age</article-title>. <source>Circulation</source> <year>2002</year>; <volume>105</volume> :<fpage>1088</fpage>–<lpage>1092</lpage>.</citation>
</ref>
<ref id="bibr7-0960327111424305">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>DJ</given-names>
</name>
</person-group>. <article-title>Fetal programming of coronary heart disease</article-title>. <source>Trends Endocrinol Metab</source> <year>2002</year>; <volume>13</volume>: <fpage>364</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr8-0960327111424305">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Osmond</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kajantie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>JG</given-names>
</name>
</person-group>. <article-title>Growth and chronic disease: findings in the Helsinki Birth Cohort</article-title>. <source>Ann Hum Biol</source> <year>2009</year>; <volume>36</volume>: <fpage>445</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr9-0960327111424305">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mimura</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fujii-Kuriyama</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Functional role of AhR in the expression of toxic effects by TCDD</article-title>. <source>Biochim Biophys Acta</source> <year>2003</year>; <volume>1619</volume>: <fpage>263</fpage>–<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr10-0960327111424305">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishimura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kawakami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ohsako</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nohara</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tohyama</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Suppressive effect of 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin on vascular remodeling that takes place in the normal labyrinth zone of rat placenta during late gestation</article-title>. <source>Toxicol Sci</source> <year>2006</year>; <volume>91</volume>: <fpage>265</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr11-0960327111424305">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line</article-title>. <source>Biol Reprod</source> <year>2005</year>; <volume>73</volume>: <fpage>172</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr12-0960327111424305">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hachisuga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Gene expression profiles by microarray analysis during matrigel-induced tube formation in a human extravillous trophoblast cell line: comparison with endothelial cells</article-title>. <source>Placenta</source> <year>2008</year>; <volume>29</volume>: <fpage>898</fpage>–<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr13-0960327111424305">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Murata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hachisuga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoxia inducible factor 1 alpha regulates matrigel-induced endovascular differentiation under normoxia in a human extravillous trophoblast cell line</article-title>. <source>Placenta</source> <year>2008</year>; <volume>29</volume>: <fpage>324</fpage>–<lpage>331</lpage>.</citation>
</ref>
<ref id="bibr14-0960327111424305">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Clements</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lonsdale</surname>
<given-names>LB</given-names>
</name>
<etal/>
</person-group>. <article-title>Partial characterization of an immortalized human trophoblast cell-line, TCL1, which possesses a CSF-1 autocrine loop</article-title>. <source>Placenta</source> <year>1996</year>; <volume>17</volume>: <fpage>137</fpage>–<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr15-0960327111424305">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Komatsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seki</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>TNF-induced apoptosis and integrin switching in human extravillous trophoblast cell line</article-title>. <source>Biol Reprod</source> <year>2003</year>; <volume>68</volume>: <fpage>1771</fpage>–<lpage>1778</lpage>.</citation>
</ref>
<ref id="bibr16-0960327111424305">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Hawley</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Hawley</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>MacDougall</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kerbel</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Establishment and characterization of first trimester human trophoblast cells with extended lifespan</article-title>. <source>Exp Cell Res</source> <year>1993</year>; <volume>206</volume>: <fpage>204</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr17-0960327111424305">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vicovac</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Aplin</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Epithelial-mesenchymal transition during trophoblast differentiation</article-title>. <source>Acta Anat</source> <year>1996</year>; <volume>156</volume>: <fpage>202</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr18-0960327111424305">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brosens</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>HG</given-names>
</name>
</person-group>. <article-title>The role of spiral arteries in the pathogenesis of preeclampsia</article-title>. <source>Obstet Gynecol Annu</source> <year>1972</year>; <volume>1</volume>: <fpage>177</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr19-0960327111424305">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMaster</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>SJ</given-names>
</name>
</person-group>. <article-title>Abnormal placentation and the syndrome of preeclampsia</article-title>. <source>Semin Nephrol</source> <year>2004</year>; <volume>24</volume>: <fpage>540</fpage>–<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr20-0960327111424305">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Whitley</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Cartwright</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>Preeclampsia: fitting together the placental, immune and cardiovascular pieces</article-title>. <source>J Pathol</source> <year>2010</year>; <volume>221</volume>: <fpage>363</fpage>–<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr21-0960327111424305">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Endocrine disruptor, dioxin (TCDD)-induced mitochondrial dysfunction and apoptosis in human trophoblast-like JAR cells</article-title>. <source>Mol Hum Reprod</source> <year>2010</year>; <volume>16</volume>: <fpage>361</fpage>–<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr22-0960327111424305">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augustowska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Magnowska</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kapiszewska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gregoraszczuk</surname>
<given-names>EL</given-names>
</name>
</person-group>. <article-title>Is the natural PCDD/PCDF mixture toxic for human placental JEG-3 cell line? The action of the toxicants on hormonal profile, CYP1A1 activity, DNA damage and cell apoptosis</article-title>. <source>Hum Exp Toxicol</source> <year>2007</year>; <volume>26</volume>: <fpage>407</fpage>–<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr23-0960327111424305">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laughlin</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Hendrickx</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Natarajan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Overstreet</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lasley</surname>
<given-names>BL</given-names>
</name>
</person-group>. <article-title>The effect of 2,3,7,8-tetrachlorodibenzo-<italic>p</italic>-dioxin (TCDD) on chorionic gonadotrophin activity in pregnant macaques</article-title>. <source>Toxicology</source> <year>2003</year>; <volume>186</volume>: <fpage>21</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr24-0960327111424305">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hendrickx</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Overstreet</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Dieter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tarantal</surname>
<given-names>AF</given-names>
</name>
<etal/>
</person-group>. <article-title>Endocrine biomarkers of early fetal loss in cynomolgus macaques (Macaca fascicularis) following exposure to dioxin</article-title>. <source>Biol Reprod</source> <year>1999</year>; <volume>60</volume>: <fpage>707</fpage>–<lpage>713</lpage>.</citation>
</ref>
<ref id="bibr25-0960327111424305">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsukimori</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tokunaga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Uchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ishimaru</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term effects of polychlorinated biphenyls and dioxin on pregnancy outcomes in women affected by the yusho incident</article-title>. <source>Environ Health Perspect</source> <year>2008</year>; <volume>116</volume>: <fpage>626</fpage>–<lpage>630</lpage>.</citation>
</ref>
<ref id="bibr26-0960327111424305">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirota</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hirohata</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Annual health examination of Yusho patients</article-title>. In: 
<person-group person-group-type="editor">
<name>
<surname>Kuratsune</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okumura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>Y</given-names>
</name>
</person-group>, editors. <source>Yusho: A Human Disaster Caused by PCBs and Related Compounds</source>. <publisher-loc>Fukuoka, Japan</publisher-loc>: <publisher-name>Kyushu University Press</publisher-name>; <year>1996</year>. pp. <fpage>249</fpage>–<lpage>266</lpage>.</citation>
</ref>
<ref id="bibr27-0960327111424305">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taki</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hisanaga</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Amagase</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Report on Yusho (chlonobiphenyls poisoning)</article-title>. <source>Fukuoka Acta Medica (in Japanese)</source> <year>1969</year>; <volume>60</volume>: <fpage>471</fpage>–<lpage>474</lpage>.</citation>
</ref>
<ref id="bibr28-0960327111424305">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Croutch</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Lebofsky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schramm</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Terranova</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Rozman</surname>
<given-names>KK</given-names>
</name>
</person-group>. <article-title>2,3,7,8-Tetrachlorodibenzo-<italic>p</italic>dioxin (TCDD) and 1,2,3,4,7,8-hexachlorodibenzo-<italic>p</italic>dioxin (HxCDD) alter body weight by decreasing insulin-like growth factor I (IGF-I) signaling</article-title>. <source>Toxicol Sci</source> <year>2005</year>; <volume>85</volume>: <fpage>560</fpage>–<lpage>571</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>